APA (7th ed.) Citation

E, C., MS, K., SY, P., K, K., HM, J., SY, L., . . . SH, K. (2026). Machine learning-based approach to guide the choice between baricitinib and tocilizumab in critical COVID-19 pneumonia treatment: A retrospective cohort study. Frontiers in medicine, 12, 1734109. https://doi.org/10.3389/fmed.2025.1734109

Chicago Style (17th ed.) Citation

E, Chang, et al. "Machine Learning-based Approach to Guide the Choice Between Baricitinib and Tocilizumab in Critical COVID-19 Pneumonia Treatment: A Retrospective Cohort Study." Frontiers in Medicine 12 (2026): 1734109. https://doi.org/10.3389/fmed.2025.1734109.

MLA (9th ed.) Citation

E, Chang, et al. "Machine Learning-based Approach to Guide the Choice Between Baricitinib and Tocilizumab in Critical COVID-19 Pneumonia Treatment: A Retrospective Cohort Study." Frontiers in Medicine, vol. 12, 2026, p. 1734109, https://doi.org/10.3389/fmed.2025.1734109.